Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04158362
Brief Title: Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer (AMBRE)

First Submitted : November 4, 2019
First Submitted that Met QC Criteria : November 6, 2019
First Posted : November 8, 2019

Last Update Submitted that Met QC Criteria : November 28, 2019
Last Update Posted : December 3, 2019